Surgical Neurology
Volume 68, Issue 3 , Pages 250-254 , September 2007

Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial

  • Mizuhiko Terasaki, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 942 35 3311; fax: +81 942 38 8179.
    • ,
  • Etsuyo Ogo, MD, PhD

      Affiliations

    • Department of Radiology, Kurume University School of Medicine, Fukuoka, Japan
    • ,
  • Shintaro Fukushima, MD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
    • ,
  • Kiyohiko Sakata, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
    • ,
  • Naohisa Miyagi, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
    • ,
  • Toshi Abe, MD, PhD

      Affiliations

    • Department of Radiology, Kurume University School of Medicine, Fukuoka, Japan
    • ,
  • Minoru Shigemori, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan

Received 22 September 2006 ,Accepted 1 November 2006.

References 

  1. Brada M, Hoang-Xuan K, Rampling R, Dietrich PY, Dirix LY, Macdonald D, et al. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol. 2001;12:259–266
  2. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987;59:1617–1625
  3. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer. 1985;56:1106–1111
  4. Busy PC. Glioblastomas. Surg Neurol. 1985;24:589–590
  5. Estlin EJ, Lashford L, Ablett S, Price L, Gowing R, Gholkar A, et al. Phase 1 study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer. 1998;78:652–661
  6. Gilbert MR, Friedman HS, Kuttesch JF, Prados MD, Olson JJ, Reaman GH, et al. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neurooncology. 2002;4:261–267
  7. Gonzalez J, Gilbert MR. Treatment of astrocytoma. Curr Opin Neurol. 2005;18:632–638
  8. Guyotat J, Signorelli F, Frappaz D, Madarassy G, Ricci AC, Bret P. Is reoperation for recurrence of glioblastoma justified?. Oncol Rep. 2000;7:899–904
  9. Hegi ME, Stupp R. Correlative studies in neuro-oncology trials: should they influence treatment?. Curr Oncol Rep. 2006;8:54–57
  10. Heppner F. The glioblastoma multiforme: a lifelong challenge to the neurosurgeon. Neurochirurgia. 1986;29:9–14
  11. Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, Marymont MH, et al. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery. 2005;57:684–692
  12. Kohshi K, Kinoshita Y, Terashima H, Konda N, Yokota A, Soejima T. Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. J Cancer Res Clin Oncol. 1996;122:676–678
  13. Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu-Mares W, et al. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group. J Clin Oncol. 1998;16:3037–3043
  14. Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, et al. Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Radiother Oncol. 2003;67:63–67
  15. Ransohoff J, Lieberman A. Surgical therapy of primary malignant brain tumors. Clin Neurosurg. 1978;25:403–411
  16. Salcman M. Survival in glioblastoma: historical perspective. Neurosurgery. 1980;7:435–439
  17. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, et al. Changing paradigms—an update on the multidisciplinary management of malignant glioma. Oncologist. 2006;11:165–180
  18. Stupp R, van den Bent MJ, Hegi ME. Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep. 2005;5:198–206
  19. Taveras JM, Thompson HG, Pool JL. Should we treat glioblastoma multiforme?. AJNR Am J Neuroradiol. 1962;87:473–479
  20. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer. 2000;83:588–593

PII: S0090-3019(06)01138-4

doi: 10.1016/j.surneu.2006.11.042

Surgical Neurology
Volume 68, Issue 3 , Pages 250-254 , September 2007

Article Tools

* Image Usage & Resolution